To determine the temporal impact heterozygous and homozygous loss of SKP2 has on CIN, each SKP2 and NT-Control clone was continually passaged for 10 weeks with cellular aliquots subjected to QuantIM analyses every four passages (p), or approximately every 2 weeks. The gene discussed is SKP2; the disease is cervical squamous intraepithelial neoplasia.